Addiction Recovery Among Opioid-Dependent Patients Treated With Injectable Subcutaneous Depot Buprenorphine: Study Protocol of a Non-randomized Prospective Observational Study (ARIDE)

Introduction: Once-weekly or once-monthly injectable depot buprenorphine is a new opioid substitution treatment (OST) medication that provides clinically relevant plasma concentrations without daily peaks. Together with a high tolerability and acceptance reported by patients, the prolonged release o...

Full description

Bibliographic Details
Main Authors: Bernd Schulte, Kirsten Lehmann, Christiane Sybille Schmidt, Elke Rühling, Bernd Weber, Ingo Schäfer, Jens Reimer, Uwe Verthein
Format: Article
Published: Frontiers Media S.A. 2020-12-01
Series:Frontiers in Psychiatry
Online Access: